Biblio
Cardiomyocyte precursors generated by direct reprogramming and molecular beacon selection attenuate ventricular remodeling after experimental myocardial infarction. Stem Cell Res Ther. 2023;14(1):296.
Generation of human induced pluripotent stem cell line (BCRTi006-A) from a patient with focal segmental glomerulosclerosis disease. Stem Cell Res. 2023;69:103070.
. Generation of two human induced pluripotent stem cell lines from a patient with Neurofibromatosis type 1 (NF1) and pathogenic NF1 gene variant c.1466 A>G BCRTi011-A as well as a first-degree healthy relative (BCRTi010-A). Stem Cell Res. 2023;71:103184.
. An inactivating human TRPC6 channel mutation without focal segmental glomerulosclerosis. Cell Mol Life Sci. 2023;80(9):265.
ISSCR standards for the use of human stem cells in basic research. Stem Cell Reports. 2023;18(9):1744-1752.
Generation of 20 human induced pluripotent stem cell lines from patients with focal segmental glomerulosclerosis (FSGS). Stem Cell Res. 2021;54:102406.
Integrated Collection of Stem Cell Bank Data, a Data Portal for Standardized Stem Cell Information. Stem Cell Reports. 2021.
The Global Alliance for iPSC Therapies (GAiT). Stem Cell Res. 2020;49:102036.
Generating Multiple Kidney Progenitors and Cell Types from Human Pluripotent Stem Cells. Methods Mol Biol. 2019;1926:103-115.
. A pathway for attesting ethical provenance of cell lines: Lessons from the European human pluripotent stem cell registry (hPSC). Stem Cell Res. 2019;40:101539.
. VEGF - Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC. Biomaterials. 2019;216:119283.
. .
The interaction of adipose-derived human mesenchymal stem cells and polyether ether ketone. Clin Hemorheol Microcirc. 2015.
Controlling Major Cellular Processes of Human Mesenchymal Stem Cells using Microwell Structures. Adv Healthc Mater. 2014.
. .